The 5-Second Trick For "3
All enrolled individuals who obtained a minimum of one particular dose of zosuquidar or placebo in the course of induction ended up monitored with the occurrence of adverse activities (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse functions were being associated with the period of extended and significant myelosuppressio